01—Abstract
Summary
Summary of the 10-K filed February 12, 2014. Cited figures are marked; the original filing is the authoritative source.
UnitedHealth Group (UNH) reported strong performance in its 2013 10-K filing, demonstrating significant revenue growth driven by both its UnitedHealthcare and Optum segments.
The company's diversified business model, encompassing health benefits and health services, contributed to an 11% increase in total revenues to $122.5 billiona. Earnings from operations grew by 4% to $9.6 billion. A key strategic move mentioned is the upcoming business realignment in 2014, which aims to further capitalize on Optum's technology and business processing capabilities.
The company also highlighted its proactive approach to managing medical costs and its ongoing efforts to adapt to the evolving healthcare landscape, including the impact of the Patient Protection and Affordable Care Act. Investors would note the company's continued expansion, particularly through acquisitions like Amil in Brazil, which significantly boosted international revenue.
The Optum segment showed particularly robust growth, with revenues up 26%b and earnings from operations up 61%, underscoring the strategic importance of its health services arm. The filing also details the company's capital management strategies, including share repurchases and dividend increases, reflecting a commitment to shareholder returns.
02—Key points
Key Highlights
- Consolidated revenues increased by 11% to $122.5 billion in 2013, driven by growth in both UnitedHealthcare and Optum segments.
- Earnings from operations increased by 4% to $9.6 billion, with Optum showing significant growth of 61%.
- UnitedHealthcare experienced organic medical enrollment growth of 4.5 million people, including 2.9 million through the TRICARE contract.
- OptumRx successfully insourced pharmacy services for 12 million UnitedHealthcare customers.
- The company acquired the remaining shares of Amil in Brazil for $1.5 billion, increasing its ownership to 90% and boosting international revenues.
- UnitedHealth Group returned significant capital to shareholders through dividends ($1.1 billion) and share repurchases ($3.2 billion).
- The company proactively managed its medical care ratio, which increased slightly to 81.5%, and discussed strategies to navigate changes brought by the Affordable Care Act.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in FY2013, UnitedHealth Group Inc kept $0.05.
- Revenue$122.49B100.0%
- Cost of revenue−$2.89B2.4%
- Gross profit$119.60B97.6%
- Operating costs−$109.97B89.8%
- Operating income$9.62B7.9%
- Interest, other & tax−$4.00B3.3%
- Net income$5.63B4.6%
Where FY2013 revenue went
$122.49B- Other operating costs: $91.03B, 74% of revenue
- SG&A: $18.94B, 15% of revenue
- Net income: $5.63B, 4.6% of revenue
- Cost of revenue: $2.89B, 2.4% of revenue
- Interest, other & tax: $4.00B, 3.3% of revenue
Kept 4.6% as net income
Full revenue history →04—Financials
Financial Highlights
Figures from 10-KFY2013filed February 12, 2014Financial Statements
FY2013 against FY2012
| Line item | FY2013FY2012 | Change |
|---|---|---|
| Revenue | $122.49B$110.62B | +10.7% |
| Cost of Revenue | $2.89B$2.52B | +14.6% |
| Gross Profit | $119.60B$108.09B | +10.6% |
| SG&A Expenses | $18.94B$17.31B | +9.4% |
| Operating Expenses | $112.87B$101.36B | +11.3% |
| Operating Income | $9.62B$9.25B | +4.0% |
| Interest Expense | $708.00M$632.00M | +12.0% |
| Net Income | $5.63B$5.53B | +1.8% |
| EPS (Basic) | $5.59$5.38 | +3.9% |
| EPS (Diluted) | $5.50$5.28 | +4.2% |
| Shares Outstanding (Basic) | 1.01B1.03B | −2.0% |
| Shares Outstanding (Diluted) | 1.02B1.05B | −2.2% |
05—Questions
Frequently Asked Questions
What was the overall financial performance of UnitedHealth Group in 2013?
UnitedHealth Group reported a strong financial performance in 2013, with consolidated revenues reaching $122.5 billion, an 11% increase year-over-year. Earnings from operations grew by 4% to $9.6 billion, demonstrating the company's ability to grow its top line while managing costs.
How did the Optum segment perform compared to UnitedHealthcare?
The Optum segment significantly outperformed UnitedHealthcare in terms of growth. Optum's revenues increased by 26% and its earnings from operations surged by 61%. In contrast, UnitedHealthcare's revenues grew by 10%, but its earnings from operations decreased by 6%, largely due to Medicare Advantage rate pressures and lower reserve development.
What are the key strategic initiatives or changes mentioned for the future?
UnitedHealth Group announced a business realignment effective January 1, 2014, where the Optum platform took over certain technology and business processing activities to pursue additional third-party commercial opportunities. This move aims to leverage Optum's capabilities more broadly.
How is UnitedHealth Group managing its exposure to regulatory changes like the Affordable Care Act (ACA)?
The company is actively managing its business in response to the ACA, which includes adapting product designs, pricing strategies, and market participation. They are incorporating industry fees into their pricing and are focused on improving quality scores and managing medical costs to mitigate the impact of regulatory changes and funding reductions, particularly in Medicare Advantage.
06—Continue